A comparison of concentration methods applied to non-infectious flavivirus recombinant antigens for use in diagnostic serological assays.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 17570536)

Published in J Virol Methods on June 14, 2007

Authors

Brandy J Russell1, Jason O Velez, Janeen J Laven, Alison J Johnson, Gwong-Jen J Chang, Barbara W Johnson

Author Affiliations

1: Diagnostic and Reference Laboratory, Centers for Disease Control and Prevention, 3150 Rampart Rd., Fort Collins, CO 80521, United States. bmk8@cdc.gov

Articles by these authors

Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis (2008) 12.72

Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis (2007) 3.87

Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol (2002) 3.02

A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. J Infect Dis (2007) 3.02

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol (2004) 2.64

Development of real-time reverse transcriptase PCR assays to detect and serotype dengue viruses. J Clin Microbiol (2006) 2.45

Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol (2003) 2.36

Notes from the field: Heartland virus disease - United States, 2012-2013. MMWR Morb Mortal Wkly Rep (2014) 2.33

Chikungunya fever in the United States: a fifteen year review of cases. Clin Infect Dis (2011) 2.25

Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends. Clin Microbiol Rev (2005) 1.91

Laboratory diagnosis of dengue virus infection: current and future perspectives in clinical diagnosis and public health. J Microbiol Immunol Infect (2005) 1.81

Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One (2009) 1.72

Development of multiplex real-time reverse transcriptase PCR assays for detecting eight medically important flaviviruses in mosquitoes. J Clin Microbiol (2006) 1.53

Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol (2008) 1.36

Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load. J Virol (2006) 1.32

Complete genome characterization of Rocio virus (Flavivirus: Flaviviridae), a Brazilian flavivirus isolated from a fatal case of encephalitis during an epidemic in Sao Paulo state. J Gen Virol (2007) 1.25

Experimental infection of cats and dogs with West Nile virus. Emerg Infect Dis (2004) 1.25

Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol (2006) 1.24

Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J Gen Virol (2009) 1.22

Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile Virus and St. Louis Encephalitis virus infections during the 2002 West Nile Virus epidemic in the United States. Clin Diagn Lab Immunol (2004) 1.14

Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People's Republic of China. Am J Trop Med Hyg (2010) 1.12

Viscerotropic disease following yellow fever vaccination in Peru. Vaccine (2009) 1.11

Evaluation of IgM antibody capture enzyme-linked immunosorbent assay kits for detection of IgM against Japanese encephalitis virus in cerebrospinal fluid samples. Am J Trop Med Hyg (2009) 1.10

Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein. Virology (2005) 1.10

Acute arboviral infections in Guinea, West Africa, 2006. Am J Trop Med Hyg (2010) 1.08

A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J Gen Virol (2007) 1.07

Strategically examining the full-genome of dengue virus type 3 in clinical isolates reveals its mutation spectra. Virol J (2005) 1.06

Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein. Virology (2006) 1.05

Comparative analysis of full genomic sequences among different genotypes of dengue virus type 3. Virol J (2008) 1.04

Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool. Am J Trop Med Hyg (2004) 1.04

Utility of IgM ELISA, TaqMan real-time PCR, reverse transcription PCR, and RT-LAMP assay for the diagnosis of Chikungunya fever. J Med Virol (2012) 1.03

Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Clin Vaccine Immunol (2008) 1.01

DNA vaccination of American robins (Turdus migratorius) against West Nile virus. Vector Borne Zoonotic Dis (2010) 1.01

Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity. J Clin Microbiol (2007) 1.01

Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J Clin Microbiol (2005) 1.01

gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol Med Microbiol (2010) 1.00

Characterization of Sepik and Entebbe bat viruses closely related to yellow fever virus. Am J Trop Med Hyg (2006) 0.98

Noninfectious recombinant antigen for detection of St. Louis encephalitis virus-specific antibodies in serum by enzyme-linked immunosorbent assay. J Clin Microbiol (2004) 0.98

Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays. Am J Trop Med Hyg (2010) 0.95

Identification of new flaviviruses in the Kokobera virus complex. J Gen Virol (2005) 0.95

Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine. PLoS Negl Trop Dis (2012) 0.95

Development of a humanized antibody with high therapeutic potential against dengue virus type 2. PLoS Negl Trop Dis (2012) 0.93

Household-based sero-epidemiologic survey after a yellow fever epidemic, Sudan, 2005. Am J Trop Med Hyg (2010) 0.93

Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement. Virol J (2012) 0.92

Ilheus virus isolate from a human, Ecuador. Emerg Infect Dis (2007) 0.90

DNA vaccination of the American crow (Corvus brachyrhynchos) provides partial protection against lethal challenge with West Nile virus. Avian Dis (2007) 0.90

Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. J Nutr (2009) 0.89

Efficacy of three vaccines in protecting Western Scrub-Jays (Aphelocoma californica) from experimental infection with West Nile virus: implications for vaccination of Island Scrub-Jays (Aphelocoma insularis). Vector Borne Zoonotic Dis (2011) 0.89

Sculpting humoral immunity through dengue vaccination to enhance protective immunity. Front Immunol (2012) 0.87

Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon. J Virol (2006) 0.86

Human monoclonal antibodies to West Nile virus identify epitopes on the prM protein. Virology (2010) 0.85

Comparison of a commercial dengue IgM capture ELISA with dengue antigen focus reduction microneutralization test and the Centers for Disease Control dengue IgM capture-ELISA. J Virol Methods (2013) 0.83

West Nile virus ecology in a tropical ecosystem in Guatemala. Am J Trop Med Hyg (2012) 0.83

Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions. J Reprod Immunol (2011) 0.82

Zoonotic infections among employees from Great Smoky Mountains and Rocky Mountain National Parks, 2008-2009. Vector Borne Zoonotic Dis (2012) 0.81

Detection of Colorado Tick Fever viral RNA in acute human serum samples by a quantitative real-time RT-PCR assay. J Virol Methods (2006) 0.81

A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines. Virology (2012) 0.81

Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein. J Virol (2004) 0.80

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Vaccine (2012) 0.79

Comparative sequence analyses of La Crosse virus strain isolated from patient with fatal encephalitis, Tennessee, USA. Emerg Infect Dis (2015) 0.78

Mutation analysis of the cross-reactive epitopes of Japanese encephalitis virus envelope glycoprotein. J Gen Virol (2012) 0.78

Detection of West Nile viral RNA from field-collected mosquitoes in tropical regions by conventional and real-time RT-PCR. Methods Mol Biol (2010) 0.78

Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis). Am J Vet Res (2011) 0.78

First detection of the Africa/Caribbean/Latin American subtype of Culex flavivirus in Asian country, Taiwan. Comp Immunol Microbiol Infect Dis (2013) 0.77

Zika Virus Infection in Patient with No Known Risk Factors, Utah, USA, 2016. Emerg Infect Dis (2017) 0.75

Microcarrier culture of COS-1 cells producing Japanese encephalitis and dengue virus serotype 4 recombinant virus-like particles. J Virol Methods (2008) 0.75

The economic value of automotive occupational health services: business metrics for performance management. J Occup Environ Med (2008) 0.75